1
H index
0
i10 index
1
Citations
Office of Health Economics | 1 H index 0 i10 index 1 Citations RESEARCH PRODUCTION: 1 Articles 6 Papers RESEARCH ACTIVITY: 4 years (2019 - 2023). See details. MORE DETAILS IN: ABOUT THIS REPORT: Permalink: http://citec.repec.org/pbr768 |
Works with: Authors registered in RePEc who have co-authored more than one work in the last five years with Simon Brassel. | Is cited by: | Cites to: |
Year | Title of citing document |
---|
Year | Title | Type | Cited |
---|---|---|---|
2023 | Value assessment of antimicrobials using the STEDI framework – How steady is the outcome? In: Health Policy. [Full Text][Citation analysis] | article | 0 |
2020 | Delivering the 2.4 Percent: Unlocking UK Pharma R&D Investment through Evidence-Based Policies In: Consulting Report. [Full Text][Citation analysis] | paper | 0 |
2020 | Realising the Broader Value of Vaccines in the UK In: Consulting Report. [Full Text][Citation analysis] | paper | 1 |
2020 | The Broader Value of Vaccines: The Return on Investment From a Governmental Perspective In: Consulting Report. [Full Text][Citation analysis] | paper | 0 |
2021 | Realising The Broader Value of Vaccines in the UK: Ready for Prime Time? In: Consulting Report. [Full Text][Citation analysis] | paper | 0 |
2021 | The Value of Vaccines in Maintaining Health System Capacity in England In: Consulting Report. [Citation analysis] | paper | 0 |
2019 | The WHO Technical Report on the Pricing of Cancer Medicines: Missing a central role for HTA and value assessment In: Research Paper. [Full Text][Citation analysis] | paper | 0 |
CitEc is a RePEc service, providing citation data for Economics since 2001. Sponsored by INOMICS. Last updated December, 10 2023. Contact: CitEc Team